OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase III Study of Second-Line Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Weekly Compared With 3-Weekly Docetaxel

HTML

Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2005.02.3739
Authors: Wolfgang Schuette, Sylke Nagel, Thomas Blankenburg, Christine Lautenschlaeger, Klaus Hans, Ernst-Wilhelm Schmidt, Ina Dittrich, Hans Schweisfurth, Ludwig Fischer von Weikersthal, Aruna Raghavachar, Angelika Reißig, Monika Serke
Institutions: Medizinische Universität Lausitz - Carl Thiem, Klinikum St. Marien Amberg, Klinikum Chemnitz, Martin Luther University Halle-Wittenberg, Friedrich Schiller University Jena
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: docetaxel, weekly dosing, non-small cell lung cancer, second-line chemotherapy, advanced non-small cell lung cancer, treatment toxicity, neutropenia, anemia, leukopenia, survival
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2147075384
FWCI: 16
Cites: 23
Cited by: 182
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms